Ipilimumab after CD34-selected allogeneic stem cell transplantation (Allo HCT) for patients with relapsed/refractory multiple myeloma (RRMM)

被引：0
|
作者：
Ghosh, Arnab [1 ]
Nagel, Katherine [1 ]
Hosszu, Kinga [1 ]
Datta, Ambika [1 ]
Thompson, Christina [1 ]
Levia, Khayla [1 ]
Kamrowski, Alyssa [1 ]
McAvoy, Devin [1 ]
Chung, David [2 ]
Landau, Heather [2 ]
Scordo, Michael [1 ]
Giralt, Sergio [1 ]
Shah, Gunjan [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Bone Marrow Transplant & Cellular Therapy, New York, NY USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-260
引用
收藏
页码：S179 / S179
页数：1
相关论文
共 50 条
  • [31] Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantation.
    Frère, P
    Pereira, M
    Fillet, G
    Beguin, Y
    BLOOD, 2004, 104 (11) : 354B - 354B
  • [32] Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma
    Lopez-Corral, Lucia
    Caballero-Velazquez, Teresa
    Lopez-Godino, Oriana
    Rosinol, Laura
    Perez-Vicente, Sabina
    Fernandez-Aviles, Francesc
    Krsnik, Isabel
    Morillo, Daniel
    Heras, Inmaculada
    Morgades, Mireia
    Rifon, Jose J.
    Sampol, Antonia
    Iniesta, Francisca
    Ocio, Enrique-Maria
    Martin, Jesus
    Rovira, Montserrat
    Cabero, Martin
    Castilla-Llorente, Cristina
    Ribera, Josep-Maria
    Torres-Juan, Marta
    Maria Moraleda, Jose
    Martinez, Carmen
    Vazquez, Alejandro
    Gutierrez, Gonzalo
    Caballero, Dolores
    San Miguel, Jesus F.
    Mateos, Maria-Victoria
    Antonio Perez-Simon, Jose
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (09) : 1703 - 1712
  • [33] Thalidomide as salvage therapy for relapsed multiple myeloma after allogeneic stem cell transplantation
    Yakoub-Agha, I
    Mohty, M
    Attal, M
    Marit, G
    Bulabois, C
    Sotto, JJ
    Gratecos, N
    Rio, B
    Vernant, JP
    Facon, T
    Jouet, JP
    BONE MARROW TRANSPLANTATION, 2004, 33 : S156 - S156
  • [34] Daratumumab as salvage therapy in relapsed/Refractory multiple myeloma patients after allogenic stem cell transplantation
    Essmann, Sonja
    von Pein, Ute-Marie
    Klyuchnikov, Evgeny
    Janson, Dietlinde
    Bonmann, Stefan
    Ayuk, Francis Ayuketang
    Wolschke, Christine
    Kroeger, Nicolaus
    BONE MARROW TRANSPLANTATION, 2019, 54 : 496 - 496
  • [35] CD34-selected stem cell boost in pediatric patients with poor graft function after allogeneic stem cell transplantation is associated with durable engraftment and excellent overall survival
    Fraint, E.
    Farooki, S.
    Klein, E.
    Prockop, S.
    Scaradavou, A.
    Curran, K.
    Cancio, M.
    Spitzer, G.
    Boelens, J. J.
    Oved, J.
    Harris, A.
    O'Reilly, R.
    Kernan, N.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 341 - 342
  • [36] Early viral complications after autologous CD34-selected peripheral blood stem cell transplantation
    Sica, S
    Sora', F
    Chiusolo, P
    Laurenti, L
    Cattani, P
    Giordano, G
    Piccirillo, N
    La Barbera, EO
    Leone, G
    BONE MARROW TRANSPLANTATION, 2000, 26 (05) : 587 - 588
  • [37] Allogeneic Stem Cell Transplantation in Refractory/Relapsed Lymphoma Patients
    Kapoor, Jyotsna
    Agrawal, Narendra
    Mehta, Pallavi
    Ahmed, Rayaz
    Bhurani, Dinesh
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S252 - S253
  • [38] CMV Seropositivity Drives T Cell Reconstitution After CD34-Selected Allogeneic HCT Despite Reduction of Viremia with Letermovir
    Cho, Christina
    Lavery, Jessica
    Ruiz, Josel
    Maloy, Molly
    Maslak, Peter
    Giralt, Sergio A.
    O'Reilly, Richard J.
    van den Brink, Marcel R. M.
    Perales, Miguel-Angel
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 122 - 123
  • [39] Early viral complications after autologous CD34-selected peripheral blood stem cell transplantation
    S Sica
    F Sora
    P Chiusolo
    L Laurenti
    P Cattani
    G Giordano
    N Piccirillo
    E Ortu La Barbera
    G Leone
    Bone Marrow Transplantation, 2000, 26 : 587 - 588
  • [40] CD34-selected stem cell boost as therapy for late graft rejection following allogeneic transplantation for sickle cell disease
    Rangarajan, Hemalatha G.
    Crowell, Sara A.
    Towerman, Alison S.
    Shenoy, Shalini S.
    BONE MARROW TRANSPLANTATION, 2022, 57 (10) : 1592 - 1594
12345